Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

19 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/19/3190788/0/en/Atea-Pharmaceuticals-to-Present-at-the-8th-Annual-Evercore-Healthcare-Conference.html

12 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/12/3186782/0/en/Atea-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

07 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/07/3183594/0/en/Atea-Pharmaceuticals-Presents-New-Data-Supporting-the-Fixed-Dose-Combination-of-Bemnifosbuvir-and-Ruzasvir-as-a-Potential-Best-in-Class-Regimen-for-Treatment-of-Hepatitis-C-Virus-I.html

05 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/05/3181255/0/en/Atea-Pharmaceuticals-to-Host-Third-Quarter-2025-Financial-Results-and-Business-Update-Conference-Call-on-November-12-2025.html

22 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/22/3170954/0/en/Atea-Pharmaceuticals-to-Host-Virtual-HCV-KOL-Panel-Event-on-November-13-2025.html

07 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/07/3162443/0/en/Atea-Pharmaceuticals-to-Present-New-Data-Supporting-Combination-of-Bemnifosbuvir-and-Ruzasvir-as-Potential-Best-in-Class-Regimen-for-Treatment-of-Hepatitis-C-Virus-Infection-at-The.html
ABOUT THIS PAGE